Advertisement
Loading...

Inspira Technologies Oxy B.H.N. Ltd.

IINNNASDAQ
Healthcare
Medical - Devices
$1.52
$0.79(109.08%)
U.S. Market opens in 64h 35m
Advertisement

Inspira Technologies Oxy B.H.N. Ltd. Fundamental Analysis

Inspira Technologies Oxy B.H.N. Ltd. (IINN) shows weak financial fundamentals with a PE ratio of -6.36, profit margin of -22.14%, and ROE of -2.78%. The company generates $0.0B in annual revenue with weak year-over-year growth of 0.00%.

Key Strengths

Operating Margin25.03%
PEG Ratio-0.06
Current Ratio1.56

Areas of Concern

ROE-2.78%
We analyze IINN's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -1912.8/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-1912.8/100

We analyze IINN's fundamental strength across five key dimensions:

Efficiency Score

Weak

IINN struggles to generate sufficient returns from assets.

ROA > 10%
-1.20%

Valuation Score

Excellent

IINN trades at attractive valuation levels.

PE < 25
-6.36
PEG Ratio < 2
-0.06

Growth Score

Weak

IINN faces weak or negative growth trends.

Revenue Growth > 5%
0.00%
EPS Growth > 10%
-749.00%

Financial Health Score

Excellent

IINN maintains a strong and stable balance sheet.

Debt/Equity < 1
0.21
Current Ratio > 1
1.56

Profitability Score

Weak

IINN struggles to sustain strong margins.

ROE > 15%
-278.14%
Net Margin ≥ 15%
-22.14%
Positive Free Cash Flow
No

Key Financial Metrics

Is IINN Expensive or Cheap?

P/E Ratio

IINN trades at -6.36 times earnings. This suggests potential undervaluation.

-6.36

PEG Ratio

When adjusting for growth, IINN's PEG of -0.06 indicates potential undervaluation.

-0.06

Price to Book

The market values Inspira Technologies Oxy B.H.N. Ltd. at 17.52 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

17.52

EV/EBITDA

Enterprise value stands at -5.49 times EBITDA. This is generally considered low.

-5.49

How Well Does IINN Make Money?

Net Profit Margin

For every $100 in sales, Inspira Technologies Oxy B.H.N. Ltd. keeps $-22.14 as profit after all expenses.

-22.14%

Operating Margin

Core operations generate 25.03 in profit for every $100 in revenue, before interest and taxes.

25.03%

ROE

Management delivers $-2.78 in profit for every $100 of shareholder equity.

-2.78%

ROA

Inspira Technologies Oxy B.H.N. Ltd. generates $-1.20 in profit for every $100 in assets, demonstrating efficient asset deployment.

-1.20%

Following the Money - Real Cash Generation

Operating Cash Flow

Inspira Technologies Oxy B.H.N. Ltd. generates limited operating cash flow of $0.00, signaling weaker underlying cash strength.

$0.00

Free Cash Flow

Inspira Technologies Oxy B.H.N. Ltd. generates weak or negative free cash flow of $0.00, restricting financial flexibility.

$0.00

FCF Per Share

Each share generates $0.00 in free cash annually.

$0.00

FCF Yield

IINN converts 0.00% of its market value into free cash.

0.00%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-6.36

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.06

vs 25 benchmark

P/B Ratio

Price to book value ratio

17.52

vs 25 benchmark

P/S Ratio

Price to sales ratio

126.67

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.21

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.56

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-2.78

vs 25 benchmark

ROA

Return on assets percentage

-1.20

vs 25 benchmark

ROCE

Return on capital employed

2.87

vs 25 benchmark

How IINN Stacks Against Its Sector Peers

MetricIINN ValueSector AveragePerformance
P/E Ratio-6.3629.35 Better (Cheaper)
ROE-278.14%705.00% Weak
Net Margin-2213.84%-53441.00% (disorted) Weak
Debt/Equity0.210.39 Strong (Low Leverage)
Current Ratio1.564.01 Neutral
ROA-119.79%-19815.00% (disorted) Weak

IINN outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Inspira Technologies Oxy B.H.N. Ltd.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

0.00%

Industry Style: Defensive, Growth, Innovation

Declining

EPS CAGR

55.64%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

-27.58%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ